By using bioinformatics and immunohistochemistry (IHC) methods, Guo et al. found that the CMTM2 expression in HCC tissues is lower than the expression level in paired parocancerous tissues (29). This evidence concerns the gene CMTM2 and hepatocellular carcinoma.